O28RRps1-XA https://histock.tw/talk/live.aspx?name=gtalk&id=1312 20250219 阿布波

台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    83.7
  • 漲跌
    ▲0.7
  • 漲幅
    +0.84%
  • 成交量
    102
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
訊聯 (1784)籌碼相關-元富-草屯 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-草屯 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/17283.8500.0084.0024280.47%
2025/02/1400.00783.7784.10-7431-1.62%
2025/02/1100.00083.7082.6004420.00%
2025/01/22182.9000.0083.1014370.23%
2025/01/1600.00181.6082.20-1455-0.22%
2025/01/0600.00381.7781.50-3475-0.63%
2025/01/0200.001.180.2880.50-1.1479-0.22%
2024/12/26182.1000.0080.9015250.19%
2024/12/20179.60179.2079.1005440.00%
2024/12/19180.1000.0079.5015470.18%
2024/12/16184.10185.0082.0005980.00%
2024/12/13190.1000.0087.2015870.17%
2024/12/12793.3300.0092.6075801.21%
2024/12/1100.00898.4597.60-8568-1.41%
2024/12/09492.6000.0092.3045610.71%
2024/12/06496.5000.0095.0045600.71%
2024/12/052100.4500.0099.6025520.36%
2024/12/0400.005100.40100.50-5550-0.91%
2024/12/0200.001.198.0096.50-1.1523-0.21%
2024/11/290.196.40295.7097.00-1.9519-0.37%
2024/11/27393.970.293.1093.102.85270.53%
2024/11/21393.7700.0093.3035840.51%
2024/11/20295.9000.0095.9025650.35%
2024/11/13189.9000.0089.5016430.16%
2024/09/24098.10397.5096.60-32,246-0.13%
2024/09/2000.002102.25101.00-22,278-0.09%
2024/09/192107.0000.00102.5022,2880.09%
2024/08/2100.001119.50117.00-12,998-0.03%
2024/08/203119.001117.00116.0022,9730.07%
2024/08/123115.503112.00112.0002,9620.00%
2024/08/0800.002107.00106.00-22,918-0.07%
2024/08/073108.001109.50108.5022,9060.07%
2024/08/062101.00298.65103.0002,8900.00%
2024/08/050100.0000.0099.5002,8530.00%
2024/07/301119.481115.00116.5002,7790.00%
2024/07/290116.5000.00113.5002,7480.00%
2024/07/232136.462132.00132.0002,6660.00%
2024/07/223144.480136.50136.0032,6470.11%
2024/07/199150.3512151.67145.50-32,572-0.12%
2024/07/1810153.859156.78161.5012,3020.04%
2024/07/120.1140.0000.00139.000.12,1770.00%
2024/07/092150.501153.00143.5012,1300.05%
2024/07/081133.0000.00146.0012,0830.05%
2024/07/051135.0000.00133.0012,0390.05%
2024/07/026134.831133.00140.0051,9350.26%
2024/07/0100.002137.50139.50-21,729-0.12%
2024/06/287122.5700.00127.0071,6230.43%
2024/06/24195.50194.3094.2001,3710.00%
2024/06/2100.00595.1293.70-51,351-0.37%
2024/06/20597.5000.0099.4051,3080.38%
2024/06/18198.40197.9096.1001,2420.00%
2024/06/17188.30188.8091.5001,1950.00%
2024/06/14186.20287.5587.70-11,153-0.09%
2024/06/13284.95285.6085.3001,1250.00%
2024/06/11383.63284.4082.8011,0510.10%
2024/06/06582.52581.1481.2009690.00%
2024/06/05382.13383.7087.0009070.00%
2024/06/04481.65383.7080.0018360.12%
2024/05/3100.00483.9082.40-4690-0.58%
2024/05/2900.00475.5074.00-4547-0.73%
2024/05/1700.00168.5069.90-1454-0.22%
2024/05/1500.00167.0066.70-1419-0.24%
2024/05/06166.9000.0066.7013960.25%
2024/05/0300.00065.9065.9003850.00%
2024/05/02066.9000.0066.5003800.00%
2024/04/26167.5000.0066.4013550.28%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音